🇺🇸 FDA
Patent

US 11576889

Methods of identifying and treating patients with HIF-2 inhibitor resistance

granted A61KA61K31/275A61K31/277

Quick answer

US patent 11576889 (Methods of identifying and treating patients with HIF-2 inhibitor resistance) held by The Board of Regents of the University of Texas System expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/275, A61K31/277, A61K45/06